跳至主要内容
临床试验/NL-OMON46493
NL-OMON46493已完成3 期

Efficacy of a predefined vitamin D dosing regimen in vitamin D-insufficient multiple myeloma patients. - Efficacy of vitamin D supplementation in multiple myeloma patients.

Medisch Centrum Leeuwarden0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subjects are (newly) diagnosed with smoldering or symptomatic multiple myeloma;
  • Subjects must be over 18 years of age;
  • Subjects must be able to give informed consent;
  • Subjects with a vitamin D level * 75 nmol/L.

排除标准

  • The use of vitamin D tablets or multivitamin tablets containing vitamin D.
  • Contraindications for the use of vitamin D:
  • Hypersensitivity to the active substance(s) or to any of the excipients;
  • Hypercalcaemia and/or hypercalciuria;
  • Nephrolithiasis and/or nephrocalcinosis;
  • Serious renal impairment;
  • Hypervitaminosis D;
  • Pseudohypoparathyroidism.

研究者

发起方
Medisch Centrum Leeuwarden

相似试验